Research Topics
Genomes and Genes
| fluorenesSummarySummary: A family of diphenylenemethane derivatives. Top Publications
Research Grants
| Scientific Experts
|
Detail Information
Publications
Malaria case-management under artemether-lumefantrine treatment policy in UgandaDejan Zurovac
Malaria Public Health and Epidemiology Group, KEMRI Wellcome Trust Research Programme, Nairobi, Kenya
Malar J 7:181. 2008..Here the quality of AL case-management is reported from Uganda; approximately one year after AL replaced combination of chloroquine and sulphadoxine-pyrimethamine (CQ+SP) as recommended first line treatment for uncomplicated malaria...
Dihydroartemisinin-piperaquine and artemether-lumefantrine for treating uncomplicated malaria in African children: a randomised, non-inferiority trialQuique Bassat
Barcelona Centre for International Health Research CRESIB, Hospital Clinic, Institut d Investigacions Biomediques August Pi i Sunyer, Universitat de Barcelona, Barcelona, Spain
PLoS ONE 4:e7871. 2009..Dihydroartemisinin-piperaquine (DHA-PQP) is a promising fixed-dose ACT with limited information on its safety and efficacy in African children...
A trial of combination antimalarial therapies in children from Papua New GuineaHarin A Karunajeewa
School of Medicine and Pharmacology, University of Western Australia, Crawley, WA, Australia
N Engl J Med 359:2545-57. 2008..Malaria control is difficult where there is intense year-round transmission of multiple plasmodium species, such as in Papua New Guinea...
Malaria drug shortages in Kenya: a major failure to provide access to effective treatmentBeth B Kangwana
Malaria Public Health and Epidemiology Group, Kenya Medical Research Institute Wellcome Trust Programme Nairobi, Kenya
Am J Trop Med Hyg 80:737-8. 2009..The shortage was in large part caused by a delayed procurement process. National ministries of health and the international community must address the current shortcomings facing antimalarial drug supply to the public sector...
A randomized trial to monitor the efficacy and effectiveness by QT-NASBA of artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment and transmission control of uncomplicated Plasmodium falciparum malaria in western KenyaPetra F Mens
Koninklijk Instituut voor de Tropen KIT Royal Tropical Institute, KIT Biomedical Research, Amsterdam, The Netherlands
Malar J 7:237. 2008....
Quality of malaria case management at outpatient health facilities in AngolaAlexander K Rowe
Centers for Disease Control and Prevention, Atlanta, USA
Malar J 8:275. 2009..Implementation was complicated by a policy that was sometimes ambiguous...
The role of pfmdr1 in Plasmodium falciparum tolerance to artemether-lumefantrine in AfricaChristin Sisowath
Malaria Research Unit, Division of Infectious Diseases, Department of Medicine, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden
Trop Med Int Health 12:736-42. 2007..e. pfmdr1 gene amplification, pfmdr1 Y184F, S1034C, N1042D, D1246Y, pfcrt S163R and PfATP6 S769N...
Measurement of adherence, drug concentrations and the effectiveness of artemether-lumefantrine, chlorproguanil-dapsone or sulphadoxine-pyrimethamine in the treatment of uncomplicated malaria in MalawiDavid J Bell
Tropical and Infectious Diseases Unit, Royal Liverpool University Hospital, Liverpool L7 8XP, UK
Malar J 8:204. 2009..The aim of this study was to investigate the impact of poor adherence on the effectiveness of AL and CPD...
Chlorproguanil-dapsone-artesunate versus artemether-lumefantrine: a randomized, double-blind phase III trial in African children and adolescents with uncomplicated Plasmodium falciparum malariaZul Premji
Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania
PLoS ONE 4:e6682. 2009....
In vivo selection of Plasmodium falciparum parasites carrying the chloroquine-susceptible pfcrt K76 allele after treatment with artemether-lumefantrine in AfricaChristin Sisowath
Infectious Diseases Unit, Department of Medicine and Karolinska Institutet, Stockholm, Sweden
J Infect Dis 199:750-7. 2009..Identification of drug-specific parasite determinants that contribute to treatment failures will provide important tools for the detection and surveillance of AL resistance...
Feasibility and acceptability of artemisinin-based combination therapy for the home management of malaria in four African sitesIkeOluwapo O Ajayi
Malaria Research Laboratories, Institute of Medical Research and Training, College of Medicine, University of Ibadan, Nigeria
Malar J 7:6. 2008..The feasibility and acceptability of incorporating ACT in HMM needs to be evaluated...
Effect of malaria rapid diagnostic tests on the management of uncomplicated malaria with artemether-lumefantrine in Kenya: a cluster randomized trialJacek Skarbinski
Malaria Branch, US Centers for Disease Control and Prevention, Atlanta, Georgia 30341 3724, USA
Am J Trop Med Hyg 80:919-26. 2009..30). RDTs could potentially improve malaria case management, but we urgently need to develop more effective strategies for implementing guidelines before large scale implementation...
Improved diagnostic testing and malaria treatment practices in ZambiaDavidson H Hamer
Center for International Health and Development, Boston University School of Public Health, Boston, Mass 02118, USA
JAMA 297:2227-31. 2007....
Impact of the large-scale deployment of artemether/lumefantrine on the malaria disease burden in Africa: case studies of South Africa, Zambia and EthiopiaKaren I Barnes
Division of Clinical Pharmacology, Department of Medicine, University of Cape Town Faculty of Health Sciences, Anzio Road, Observatory, 7925, South Africa
Malar J 8:S8. 2009..Artemisinin-based combination therapy has made a substantial contribution to reducing the burden of malaria in sub-Saharan Africa...
Artemether-lumefantrine versus dihydroartemisinin-piperaquine for falciparum malaria: a longitudinal, randomized trial in young Ugandan childrenEmmanuel Arinaitwe
Makerere University University of California San Francisco Research Collaboration, University of California, San Francisco 94143, USA
Clin Infect Dis 49:1629-37. 2009..However, which therapies are optimal is a matter of debate. We aimed to compare the short- and longer-term efficacy of 2 leading therapies in a cohort of young Ugandan children...
Pharmacokinetics and pharmacodynamics of lumefantrine (benflumetol) in acute falciparum malariaF Ezzet
Novartis Pharma AG, Basel, Switzerland
Antimicrob Agents Chemother 44:697-704. 2000..The high cure rates with the two six-dose regimens resulted from increased AUC and increased time at which lumefantrine concentrations were above the in vivo MIC...
Overuse of artemisinin-combination therapy in Mto wa Mbu (river of mosquitoes), an area misinterpreted as high endemic for malariaCharles Mwanziva
Department of Medical Microbiology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
Malar J 7:232. 2008..This study describes diagnostic and treatment practices in Mto wa Mbu, an area that used to be hyperendemic for malaria, but where no recent assessments of transmission intensity have been conducted...
Community response to artemisinin-based combination therapy for childhood malaria: a case study from Dar es Salaam, TanzaniaVinay R Kamat
Department of Anthropology, University of British Columbia, Vancouver, Canada
Malar J 9:61. 2010..The paper specifically examines the perceived efficacy of ALu as articulated by the mothers of young children diagnosed with malaria and prescribed ALu...
Treatment with coartem (artemether-lumefantrine) in Papua New GuineaSonja Schoepflin
Swiss Tropical Institute, Basel, Switzerland
Am J Trop Med Hyg 82:529-34. 2010..In contrast to the situation in classic drug trials with ideal treatment conditions, our field survey highlights potential problems with unsupervised usage of Coartem in routine clinical practice and under program conditions...
SMS for Life: a pilot project to improve anti-malarial drug supply management in rural Tanzania using standard technologyJim Barrington
SMS for Life Program Director, Forum 1 P 94, Novartis Campus, CH 4056 Basel, Switzerland
Malar J 9:298. 2010..Lack of visibility of anti-malarial stock levels at the health facility level is an important contributor to this problem...
Adherence to and acceptability of artemether-lumefantrine as first-line anti-malarial treatment: evidence from a rural community in TanzaniaAbdunoor M Kabanywanyi
Ifakara Health Institute, P, O, Box 78373, Kiko Avenue, Old Bagamoyo Road, Mikocheni, Dar es Salaam, Tanzania
Malar J 9:48. 2010..Controlled clinical trials have shown that a six-dose regimen of artemether-lumefantrine (AL) therapy for uncomplicated Plasmodium falciparum malaria results in cure rates >95% with good tolerability...
Implementation of Home based management of malaria in children reduces the work load for peripheral health facilities in a rural district of Burkina FasoAlfred B Tiono
Centre National de Recherche et de Formation sur Paludisme, Ministère de Santé, Ouagadougou, Burkina Faso, West Africa
Malar J 7:201. 2008..However, the potential fall-out of this community-based strategy on the work burden at the peripheral health facilities level has never been investigated...
Health facility and health worker readiness to deliver new national treatment policy for malaria in KenyaJ Njogu
Malaria Public Health and Epidemiology Group, KEMRI Wellcome Trust Research Programme, P O Box 43640 00100, Nairobi, Kenya
East Afr Med J 85:213-21. 2008..To evaluate health facility and health worker readiness to deliver new artemether-lumefantrine (AL) treatment policy for uncomplicated malaria in Kenya...
Why don't health workers prescribe ACT? A qualitative study of factors affecting the prescription of artemether-lumefantrineBeatrice Wasunna
Eastern and Southern Africa Centre of International Parasite Control ESACIPAC KEMRI, P O Box 54840 00200, Nairobi, Kenya
Malar J 7:29. 2008..New national guidelines on the diagnosis, treatment and prevention were developed and disseminated to health workers together with in-service training...
[Efficacy of dihydroartemisinin-piperaquine and artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in Hainan, China]Shan Qing Wang
Hainan Provincial Center for Disease Control and Prevention, Haikou 570203, China
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 26:50-2. 2008....
Efficacy and tolerability of four antimalarial combinations in the treatment of uncomplicated Plasmodium falciparum malaria in SenegalBabacar Faye
Laboratoire de Parasitologie Mycologie, Faculte de Medecine, Pharmacie et Odontologie, Universite Cheikh Anta Diop, Dakar, Senegal
Malar J 6:80. 2007....
Treatment of asymptomatic carriers with artemether-lumefantrine: an opportunity to reduce the burden of malaria?Bernhards Ogutu
Walter Reed Project Centre for Clinical Research Kenya Medical Research Institute, Nairobi, Kenya
Malar J 9:30. 2010..The potential of this intervention was considered by key scientists in the field at an Advisory Board meeting held in Basel, in April 2009. This article summarizes the discussions that took place among the participants...
Translation of artemether-lumefantrine treatment policy into paediatric clinical practice: an early experience from KenyaD Zurovac
Malaria Public Health and Epidemiology Group, KEMRI Wellcome Trust Research Programme, Nairobi, Kenya
Trop Med Int Health 13:99-107. 2008..To describe the quality of outpatient paediatric malaria case-management approximately 4-6 months after artemether-lumefantrine (AL) replaced sulfadoxine-pyrimethamine (SP) as the nationally recommended first-line therapy in Kenya...
Comparative study on the in vitro activity of lumefantrine and desbutyl-benflumetol in fresh isolates of Plasmodium vivax from ThailandDaniela K Pirker-Krassnig
Division of Specific Prophylaxis and Tropical Medicine, Center for Physiology and Pathophysiology, Medical University of Vienna, Austria
Wien Klin Wochenschr 116:47-52. 2004..0. The activity of desbutyl-benflumetol in P. vivax exceeds that of lumefantrine by one order of magnitude, suggesting a high, hitherto unexploited therapeutic potential of desbutyl-benflumetol...
Crystal structures of 2-acetylaminofluorene and 2-aminofluorene in complex with T7 DNA polymerase reveal mechanisms of mutagenesisShuchismita Dutta
Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, 240 Longwood Avenue, Boston, MA 02115, USA
Proc Natl Acad Sci U S A 101:16186-91. 2004..In contrast, the dG-AF base at the templating position is not well defined by the electron density, consistent with weak binding to the polymerase and a possible interchange of this adduct between the syn and anti conformations...
Comparison of HPLC, UV spectrophotometry and potentiometric titration methods for the determination of lumefantrine in pharmaceutical productsIsabela da Costa César
Departamento de Produtos Farmacêuticos, Faculdade de Farmacia, Universidade Federal de Minas Gerais, Av Pres Antônio Carlos 6627, 31270 901 Belo Horizonte, MG, Brazil
J Pharm Biomed Anal 48:223-6. 2008..The end point was potentiometrically determined. The three evaluated methods showed to be adequate to quantify lumefantrine in raw materials, while HPLC and UV methods presented the most reliable results for the analyses of tablets...
Site-specific incorporation of N-(deoxyguanosin-8-yl)-2-acetylaminofluorene (dG-AAF) into oligonucleotides using modified 'ultra-mild' DNA synthesisLudovic C J Gillet
Institute for Molecular Cancer Research, , , Switzerland
Nucleic Acids Res 33:1961-9. 2005..Our synthetic approach should facilitate comprehensive studies of the mechanisms of repair and mutagenesis induced by dG-AAF adducts in DNA and should be of general use for the incorporation of base-labile functionalities into DNA...
Coartemether (artemether and lumefantrine): an oral antimalarial drugWalther H Wernsdorfer
Department of Specific Prophylaxis and Tropical Medicine, University of Vienna, Kinderspitalgasse 15, A 1095 Vienna, Austria
Expert Rev Anti Infect Ther 2:181-96. 2004..Extensive cardiological investigations have demonstrated the high cardiac safety of coartemether...
Development and validation of an automated solid-phase extraction and liquid chromatographic method for determination of lumefantrine in capillary blood on sampling paperD Blessborn
Dalarna University College, Borlange, Sweden
J Pharm Biomed Anal 45:282-7. 2007..Lumefantrine could be estimated accurately enough to assess bioavailability and treatment compliance on day 7 (i.e. 4 days after the last dose) after a standard regimen with the lumefantrine/artemether combination...
Simultaneous determination of artemether and lumefantrine in fixed dose combination tablets by HPLC with UV detectionIsabela da Costa César
Departamento de Produtos Farmacêuticos, Faculdade de Farmacia, Universidade Federal de Minas Gerais, Av Pres Antônio Carlos 6627, 31270 901 Belo Horizonte, MG, Brazil
J Pharm Biomed Anal 48:951-4. 2008..Four batches of artemether-lumefantrine tablets were assayed by the validated method. The artemether contents in the tablets varied from 98.61% to 103.35%, while lumefantrine contents were 97.92-100.48%...
Relative importance of aldose reductase versus nonenzymatic glycosylation on sugar cataract formation in diabetic ratsP F Kador
Laboratory of Ocular Therapeutics, National Eye Institute, NIH, Bethesda, Maryland 20892 1850, USA
J Ocul Pharmacol Ther 16:149-60. 2000..These results support the concept that sugar cataract formation is initiated by the aldose reductase catalyzed intracellular accumulation of polyols and that these sugar cataracts can be prevented through inhibition of aldose reductase...
Early clinical development of artemether-lumefantrine dispersible tablet: palatability of three flavours and bioavailability in healthy subjectsSalim Abdulla
Ifakara Health Institute, Ifakara and Dar es Salaam, Tanzania
Malar J 9:253. 2010....
The comparative efficacy and tolerability of CGP 56697 (artemether + lumefantrine) versus halofantrine in the treatment of uncomplicated falciparum malaria in travellers returning from the Tropics to The Netherlands and FranceM van Agtmael
Department of Infectious Diseases, Tropical Medicine and AIDS, Academic Medical Centre, Amsterdam, The Netherlands
Int J Antimicrob Agents 12:159-69. 1999..For travellers contracting malaria abroad, we propose a six-dose regimen of CGP 56697 over 3 days...
Effect of an aldose reductase inhibitor on alveolar bone loss associated with periodontitis in diabetic ratsPeter F Kador
College of Pharmacy, University of Nebraska Medical Center, Omaha, NE 68198, USA
Postgrad Med 122:138-44. 2010..05). These results suggest that the sorbitol pathway plays a critical role in the pathophysiological mechanism(s) of diabetic periodontitis and that AR may be a direct pharmacological target for the treatment for this disease...
Dihydroartemisinin-piperaquine versus artemether-lumefantrine, in the treatment of uncomplicated Plasmodium falciparum malaria in central SudanI Adam
University of Khartoum, Sudan
Ann Trop Med Parasitol 104:319-26. 2010..Thus, both treatments appeared effective and safe for the treatment of uncomplicated P. falciparum malaria in central Sudan, although treatment with DHA-P (which requires a simpler dosing regimen) might be preferred to treatment with AL...
Pfmdr1 copy number and arteminisin derivatives combination therapy failure in falciparum malaria in CambodiaPharath Lim
Institut Pasteur in Cambodia, Phnom Penh, Cambodia
Malar J 8:11. 2009....
Piloting the global subsidy: the impact of subsidized artemisinin-based combination therapies distributed through private drug shops in rural TanzaniaOliver J Sabot
Malaria Control Team, Clinton Foundation HIV AIDS Initiative, Boston, Massachusetts, USA
PLoS ONE 4:e6857. 2009..To overcome this challenge, a global ACT subsidy has been proposed. We tested this proposal through a pilot program in rural Tanzania...
Safety and tolerability of artemether-lumefantrine versus dihydroartemisinin-piperaquine for malaria in young HIV-infected and uninfected childrenShereen Katrak
Oregon Health and Science University, Portland, USA
Malar J 8:272. 2009..However, there is limited data on the safety and tolerability of these drugs, especially in young children and patients co-infected with HIV...
Adherence to a six-dose regimen of artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in UgandaCarole Fogg
Epicentre, Paris, France
Am J Trop Med Hyg 71:525-30. 2004..The high adherence to artemether-lumefantrine found in our study suggest that this drug is likely to be very effective in Mbarara provided that patients receive clear dosage explanations...
Drug procurement, the Global Fund and misguided competition policiesRichard Tren
Africa Fighting Malaria, Washington, DC, USA
Malar J 8:305. 2009..A tender process based primarily on price cannot account for a company's ability to consistently supply sufficient product in time...
Decreasing pfmdr1 copy number in plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisininAmar bir Singh Sidhu
Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, Bronx, NY 10461, USA
J Infect Dis 194:528-35. 2006..These results highlight the importance of pfmdr1 copy number in determining P. falciparum susceptibility to multiple agents currently being used to combat malaria caused by multidrug-resistant parasites...
Efficacy of chloroquine + sulfadoxine--pyrimethamine, mefloquine + artesunate and artemether + lumefantrine combination therapies to treat Plasmodium falciparum malaria in the Chittagong Hill Tracts, BangladeshI V van den Broek
MSF UK, London, UK
Trans R Soc Trop Med Hyg 99:727-35. 2005..A change to artemisinin-based combination therapy is recommended. Both Coartem and MQ + AS appear to be good options, effective in curing P. falciparum malaria and in preventing recrudescences following treatment...
Efficacy and safety of artemether-lumefantrine (Coartem) tablets (six-dose regimen) in African infants and children with acute, uncomplicated falciparum malariaCatherine Falade
Malaria Research Laboratories, IMRAT, College of Medicine, University of Ibadan, Ibadan, Nigeria
Trans R Soc Trop Med Hyg 99:459-67. 2005..The co-artemether six-dose regimen, treating acute uncomplicated falciparum malaria in African children, achieved rapid parasite clearance and a high cure rate. Treatment was generally safe and well tolerated...
Artemether-lumefantrine versus artesunate plus amodiaquine for treating uncomplicated childhood malaria in Nigeria: randomized controlled trialMartin Meremikwu
Calabar Institute of Tropical Disease Research and Prevention, GPO Box 1211, Calabar, Nigeria
Malar J 5:43. 2006..The therapeutic efficacy of artesunate plus amodiaquine and artemether/lumefantrine were assessed in an area of Nigeria with high levels of Plasmodium falciparum resistance to chloroquine and sulphadoxine-pyrimethamine...
Cost-effectiveness study of three antimalarial drug combinations in TanzaniaVirginia Wiseman
Department of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, United Kingdom
PLoS Med 3:e373. 2006..Cost is a major barrier to deployment. There is little evidence from field trials on the cost-effectiveness of these new combinations...
Efficacy and safety of the six-dose regimen of artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in adolescents and adults: a pooled analysis of individual patient data from randomized clinical trialsEdgar A Mueller
Institute for Clinical Pharmacology, Public Health Research Association Saxony, Medical Faculty, Technical University, Fiedlerstrasse 27, D 01307 Dresden, Germany
Acta Trop 100:41-53. 2006..The main finding of our analysis is that the six-dose regimen of co-artemether is more effective than the four-dose regimen in adolescents and adults without compromising safety...
Pharmacokinetics and electrocardiographic pharmacodynamics of artemether-lumefantrine (Riamet) with concomitant administration of ketoconazole in healthy subjectsGilbert Lefèvre
Clinical Pharmacology, Novartis Pharma Ltd, WSJ 27 3 102, CH 4002 Basel, Switzerland
Br J Clin Pharmacol 54:485-92. 2002..To evaluate whether the potent CYP3A4 inhibitor ketoconazole has any influence on the pharmacokinetic and electrocardiographic parameters of the antimalarial co-artemether (artemether-lumefantrine) in healthy subjects...
[Surveillance of falciparum malaria susceptibility to antimalarial drugs and policy change in the Comoros]R Silai
Programme National de Lutte contre le Paludisme, Moroni, Union des Comores
Bull Soc Pathol Exot 100:6-9. 2007..4% in the 3 sites with a follow-up of 28 days. No serious drug related adverse event was reported...
Understanding the pharmacokinetics of CoartemAbdoulaye Djimde
Malaria Research and Training Center, Department of Epidemiology of Parasitic Diseases, Faculty of Medicine, Pharmacy and Odonto Stomatology, University of Bamako, PO Box 1805 Point G, Bamako, Mali
Malar J 8:S4. 2009..However, additional data would be warranted to better characterize artemether and lumefantrine pharmacokinetics in patients with hepatic impairment, in pregnant women, and in patients undergoing HIV/AIDS chemotherapy...
The use of artemether-lumefantrine by febrile children following national implementation of a revised drug policy in KenyaCaroline W Gitonga
Malaria Public Health and Epidemiology Group, Centre for Geographic Medicine Research Coast, Nairobi, Kenya
Trop Med Int Health 13:487-94. 2008..To examine access to, timing and use of artemisinin-based combination therapy among rural Kenyan febrile children before and following the introduction of artemether-lumefantrine (AL) as first-line antimalarial drug policy...
Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treating uncomplicated malaria: a randomized trial to guide policy in UgandaAdoke Yeka
Uganda Malaria Surveillance Project, Kampala, Uganda
PLoS ONE 3:e2390. 2008..We compared the efficacy and safety of AL with DP in Kanungu, an area of moderate malaria transmission...
Safety and tolerability of combination antimalarial therapies for uncomplicated falciparum malaria in Ugandan childrenCatherine Maiteki-Sebuguzi
Department of Medicine, Makerere University, Kampala, Uganda
Malar J 7:106. 2008..This study compared the safety and tolerability of three combination antimalarial regimens in a cohort of Ugandan children...
From chloroquine to artemisinin-based combination therapy: the Sudanese experienceE M Malik
National Malaria Control Programme, Khartoum, Sudan
Malar J 5:65. 2006..Relevant published and unpublished documents were reviewed. Data and information obtained were compiled into a structured format...
Comparative clinical trial of two-fixed combinations dihydroartemisinin-napthoquine-trimethoprim (DNP) and artemether-lumefantrine (Coartem/Riamet) in the treatment of acute uncomplicated falciparum malaria in ThailandS Krudsood
Department of Tropical Hygiene, Faculty of Tropical Medicine, Mahidol University, Ratchadewee, Bangkok, Thailand
Southeast Asian J Trop Med Public Health 34:316-21. 2003..No serious adverse events occurred. We concluded that both DNP and Coartem/ Riamet were safe, well tolerated and highly efficacious in the treatment of acute uncomplicated falciparum malaria in Thailand...
Monitoring the therapeutic efficacy of antimalarials against uncomplicated falciparum malaria in ThailandC Rojanawatsirivej
Malaria Division, Ministry of Public Health, Nonthaburi, Thailand
Southeast Asian J Trop Med Public Health 34:536-41. 2003....
Multiple dose pharmacokinetics of artemether in Chinese patients with uncomplicated falciparum malariaM A van Agtmael
Department of Clinical Pharmacology and Pharmacotherapy, Academic Medical Center, Amsterdam, The Netherlands
Int J Antimicrob Agents 12:151-8. 1999..We suggest that auto-induction of gut mucosa enzymes and/or liver enzymes causes a time-dependent increase in first-pass metabolisation of artemether...
Interaction trial between artemether-lumefantrine (Riamet) and quinine in healthy subjectsGilbert Lefèvre
Novartis Pharma Ltd, Basle, Switzerland
J Clin Pharmacol 42:1147-58. 2002....
Pharmacokinetic study of artemether-lumefantrine given once daily for the treatment of uncomplicated multidrug-resistant falciparum malariaElizabeth A Ashley
Shoklo Malaria Research Unit, Mae Sot, Thailand
Trop Med Int Health 12:201-8. 2007..If the fixed antimalarial drug combination artemether-lumefantrine (AL) could be given once daily, this should improve adherence and thus effectiveness and lower the risk of selecting for resistance...
How much fat is necessary to optimize lumefantrine oral bioavailability?Elizabeth A Ashley
Shoklo Malaria Research Unit, Mae Sot, Thailand
Trop Med Int Health 12:195-200. 2007..The aim of this study was to describe the dose-response relationship between coadministration of fat and relative lumefantrine bioavailability, in order to determine the minimum amount of fat necessary to optimize absorption...
In vitro antimalarial drug susceptibility and pfcrt mutation among fresh Plasmodium falciparum isolates from the Lao PDR (Laos)Mayfong Mayxay
Wellcome Trust Mahosot Hospital Oxford Tropical Medicine Research Collaboration, Mahosot Hospital, Vientiane, Lao PDR
Am J Trop Med Hyg 76:245-50. 2007..P. falciparum in Laos is multi-drug resistant; antimalarial immunity resulting from the use of ineffective chloroquine before 2005 probably contributes significantly to the therapeutic responses in clinical trials...
Artemether-lumefantrine versus amodiaquine plus sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Burkina Faso: a randomised non-inferiority trialIssaka Zongo
Institut de recherche en sciences de la sante, Bobo Dioulasso, Burkina Faso
Lancet 369:491-8. 2007..Our aim was to compare the risk of recurrent parasitaemia in patients given artemether-lumefantrine with that in those given amodiaquine plus sulfadoxine-pyrimethamine for uncomplicated malaria...
Antimalarial drug combinations in vastly different settingsRichard H Morrow
Department of International Health, Health Systems Program, Bloomberg School of Public Health, John Hopkins University, Baltimore, MD 21205, USA
Lancet 369:444-5. 2007
Therapeutic efficacy of artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in BangladeshRashidul Haque
Centre for Health and Population Research, International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh
Am J Trop Med Hyg 76:39-41. 2007..82 +/- 12.14 hours) and parasite (30.36 +/- 19.43 hours) clearance. These data suggest that artemether-lumefantrine is a highly efficacious and well-tolerated treatment for uncomplicated P. falciparum malaria in Bangladesh...
Efficacy of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in northwest CambodiaMey Bouth Denis
National Center for Parasitology, Entomology and Malaria Control, Phnom Penh, Cambodia
Trop Med Int Health 11:1800-7. 2006..Further investigations are necessary to determine whether resistance of Plasmodium falciparum isolates to lumefantrine is present in the region...
The new drug combinations: their place in the treatment of uncomplicated Plasmodium falciparum malariaMartin Danis
, , , , , 75651 Paris Cedex 13, France
Fundam Clin Pharmacol 17:155-60. 2003..A review of the mein drug combinations, which are recently registered or are still under development, was undertaken, with special attention to the atovaquone-proguanil and artemether-lumefantrine combination...
[Riamet: a new antimalarial for curative treatment of malaria]L Delhaes
Laboratoire de Parasitologie-Mycologie, L.D, E.F, E.D, D.C, , Lille, France
Med Trop (Mars) 62:485-7. 2002
Artemisinin-based combination therapy reduces expenditure on malaria treatment in KwaZulu Natal, South AfricaCharlotte Muheki
Health Sciences Faculty, University of Cape Town, South Africa
Trop Med Int Health 9:959-66. 2004..However, the relevance of these findings requires careful consideration in countries with currently effective treatment policies and higher intensity malaria transmission...
A randomized trial of artesunate-sulfamethoxypyrazine-pyrimethamine versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in MaliIssaka Sagara
Malaria Research and Training Center, Department of Epidemiology of Parasitic Diseases, Faculty of Medicine, Pharmacy, and Odonto Stomatology, University of Bamako, Bamako, Mali
Am J Trop Med Hyg 75:630-6. 2006..0%, respectively (P = 0.08). No serious adverse events occurred. Artesunate-sulfamethoxypyrazine-pyrimethamine is well-tolerated and effective against P. falciparum malaria. It showed an additional benefit of preventing new infections...
Influence of consecutive-day blood sampling on polymerase chain reaction-adjusted parasitological cure rates in an antimalarial-drug trial conducted in TanzaniaAndreas Martensson
Infectious Diseases Unit, Department of Medicine, Karolinska University Hospital, Stockholm 17176, Sweden
J Infect Dis 195:597-601. 2007..Interpretation of PCR-adjusted results will significantly depend on methodology...
Amodiaquine-artesunate vs artemether-lumefantrine for uncomplicated malaria in Ghanaian children: a randomized efficacy and safety trial with one year follow-upGeorge O Adjei
Department of Child Health, Korle Bu Teaching Hospital, University of Ghana Medical School, P O Box KB 4236, Accra, Ghana
Malar J 7:127. 2008..However, there is little information on the efficacy of these regimens on subsequent episodes beyond 28 days, or on the safety of repeated treatments...
Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina FasoIssaka Zongo
Institut de recherche en sciences de la sante, Bobo Dioulasso, Burkina Faso
Clin Infect Dis 45:1453-61. 2007....
Comparison of artemether-lumefantrine with sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in eastern NepalSuman Thapa
Sukraraj Tropical and Infectious Disease Hospital, Kathmandu, Nepal
Am J Trop Med Hyg 77:423-30. 2007..Dhfr and dhps mutations were not associated with outcome. AL is more effective than SP for uncomplicated malaria in Nepal, but regular monitoring of its efficacy should be carried out if this combination therapy is introduced...
The antischistosomal efficacies of artesunate-sulfamethoxypyrazine-pyrimethamine and artemether-lumefantrine administered as treatment for uncomplicated, Plasmodium falciparum malariaI Adam
Faculty of Medicine, University of Khartoum, P O Box 102, Khartoum, Sudan
Ann Trop Med Parasitol 102:39-44. 2008..These results indicate that AS-SMP and AT-LU are currently very effective treatments not only for uncomplicated, P. falciparum malaria but also for S. mansoni infections...
Therapeutic efficacy and effects of artemether-lumefantrine and amodiaquine-sulfalene-pyrimethamine on gametocyte carriage in children with uncomplicated Plasmodium falciparum malaria in southwestern NigeriaAkintunde Sowunmi
Department of Pharmacology and Therapeutics and Institute for Medical Research and Training, University of Ibadan, Ibadan, Nigeria
Am J Trop Med Hyg 77:235-41. 2007..Both regimens were well tolerated. Artemether-lumefantrine clears parasitemia more rapidly than ASP but both combinations are effective in treatment of uncomplicated P. falciparum malaria in Nigerian children...
Treatment of acute uncomplicated falciparum malaria with artemether-lumefantrine in nonimmune populations: a safety, efficacy, and pharmacokinetic studyChristoph Hatz
Medical Department, Swiss Tropical Institute, Basel, Switzerland
Am J Trop Med Hyg 78:241-7. 2008..In conclusion, the six-dose regimen of artemether-lumefantrine was effective and well tolerated in the treatment of acute uncomplicated falciparum malaria in nonimmune patients...
Effectiveness of co-artemether in an unsupervised outpatient setting for the treatment of falciparum malariaS Toovey
SAA Netcare Travel Clinics, Johannesburg, South Africa
Travel Med Infect Dis 6:29-31. 2008..To assess artemether-lumefantrine effectiveness in the treatment of falciparum malaria in an unsupervised outpatient setting in Africa...
Resistance-mediating Plasmodium falciparum pfcrt and pfmdr1 alleles after treatment with artesunate-amodiaquine in UgandaSamuel L Nsobya
Department of Medicine, Makerere University, Kampala, Uganda
Antimicrob Agents Chemother 51:3023-5. 2007..For pfmdr1, 86Y and 1246Y were common at baseline and their prevalences were significantly higher in new isolates after therapy, indicating that treatment selected for mutations associated with a decreased response to amodiaquine...
[Efficacy of therapeutic combinations with artemisinin derivatives in the treatment of non complicated malaria in Burundi.]Athanase Ndayiragije
, , Bujumbura, Burundi
Trop Med Int Health 9:673-9. 2004..During a consensus workshop, the Ministry of Public Health agreed on the combination of artesunate and amodiaquine as the first line drug for the treatment of uncomplicated falciparum malaria in Burundi including epidemic outbreak...
High efficacy of two artemisinin-based combinations (artemether-lumefantrine and artesunate plus amodiaquine) for acute uncomplicated malaria in Ibadan, NigeriaC O Falade
Department of Clinical Pharmacology, University College Hospital, Ibadan, Nigeria
Trop Med Int Health 13:635-43. 2008..To test the hypothesis that artesunate plus amodiaquine (ASAQ) is as effective as artemether-lumefantrine (AL) in the treatment of acute uncomplicated malaria in Nigerian children...
Combination therapy for uncomplicated falciparum malaria in Ugandan children: a randomized trialGrant Dorsey
Department of Medicine, San Francisco General Hospital, University of California, San Francisco, CA 94143, USA
JAMA 297:2210-9. 2007..Combination therapy is now widely advocated as first-line treatment for uncomplicated malaria in Africa. However, it is not clear which treatment regimens are optimal or how to best assess comparative efficacies in highly endemic areas...
Complement activation in experimental human malaria infectionMeta Roestenberg
Radboud University Nijmegen Medical Center, Postbus 9101, 6500 HB Nijmegen, The Netherlands
Trans R Soc Trop Med Hyg 101:643-9. 2007..Treatment with artemether/lumefantrine was followed by classical and alternative pathway complement activation, without evidence for mannan-binding-lectin-mediated complement activation...
Case report: combination artemether-lumefantrine and haemolytic anaemia following a malarial attackStéphane Mérat
Department of Anaesthesiology, HIA du Valde Grâce, 74 Bd Port Royal, 75005 Paris, France
Trans R Soc Trop Med Hyg 97:433-4. 2003....
Adherence to a combination of artemether and lumefantrine (Coartem) in Kajo Keji, southern SudanE Depoortere
Epicentre, 42 bis boulevard Richard Lenoir, 75011 Paris, France
Ann Trop Med Parasitol 98:635-7. 2004
Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparisonA Ratcliff
International Health Programme, Menzies School of Health Research and Charles Darwin University, Darwin, Northern Territory, Australia
Lancet 369:757-65. 2007..Our aim was to compare the safety and efficacy of dihydroartemisinin-piperaquine with that of artemether-lumefantrine in patients with uncomplicated malaria caused by multidrug-resistant P falciparum and P vivax...
Malaria treatment failures after artemisinin-based therapy in three expatriates: could improved manufacturer information help to decrease the risk of treatment failure?Yves Jackson
Travel and Migration Medicine Unit, Geneva University Hospital, Rue Micheli du Crest 24, 1211 Geneva 14, Switzerland
Malar J 5:81. 2006..falciparum acquired in Africa, who failed to respond to artemisinin-based therapy. Sub-therapeutic dosing in accordance with the manufacturers' recommendations was the probable cause...
The effects of artemether-lumefantrine vs amodiaquine-sulfalene-pyrimethamine on the hepatomegaly associated with Plasmodium falciparum malaria in childrenA Sowunmi
Department of Pharmacology and Therapeutics and Institute for Medical Research and Training, University of Ibadan, Ibadan, Nigeria
Parasitol Res 100:511-7. 2007....
Efficacy of three artemisinin combination therapies for the treatment of uncomplicated Plasmodium falciparum malaria in the Republic of CongoIngrid van den Broek
Medecins Sans Frontieres, London, UK
Malar J 5:113. 2006..Presented here are the results of a comparative trial on the efficacy of three artemisinin-based combinations conducted from May to October 2004, in Pool Province, Republic of Congo...
In vitro sensitivity of Plasmodium falciparum to lumefantrine in north-western ThailandJulia Beatrice Pilz
Institute of Microbiology, Humboldt-University, Berlin, Germany
Wien Klin Wochenschr 116:41-6. 2004..falciparum infections to combined treatment with artesunate + mefloquine. The EC9o and EC99 data of 2002 for lumefantrine in the study area suggest fully curative clinical-parasitological efficacy...
Operational response to malaria epidemics: are rapid diagnostic tests cost-effective?Estelle Rolland
Epicentre, Paris, France
Trop Med Int Health 11:398-408. 2006..To compare the cost-effectiveness of malaria treatment based on presumptive diagnosis with that of malaria treatment based on rapid diagnostic tests (RDTs)...
Supervised versus unsupervised intake of six-dose artemether-lumefantrine for treatment of acute, uncomplicated Plasmodium falciparum malaria in Mbarara, Uganda: a randomised trialPatrice Piola
Epicentre, 8 rue Saint Sabin, 75011 Paris, France
Lancet 365:1467-73. 2005....
Amodiaquine alone, amodiaquine+sulfadoxine-pyrimethamine, amodiaquine+artesunate, and artemether-lumefantrine for outpatient treatment of malaria in Tanzanian children: a four-arm randomised effectiveness trialTheonest K Mutabingwa
Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK
Lancet 365:1474-80. 2005..The WHO-packaged six-dose regimen of artemether-lumefantrine is effective taken unsupervised, although cost is a major limitation...
The efficacies of artesunate-sulfadoxine-pyrimethamine and artemether-lumefantrine in the treatment of uncomplicated, Plasmodium falciparum malaria, in an area of low transmission in central SudanA O Mohamed
Department of Biochemistry, Faculty of Medicine and Health Sciences, University of El Imam El Mahdi, P O Box 209, Kosti, Sudan
Ann Trop Med Parasitol 100:5-10. 2006..No moderate or severe adverse side-effects, clinical failures or parasitological failures were observed among these 137 patients. ACT therefore appear both efficacious and safe for the treatment of uncomplicated malaria in central Sudan...
A clinical and pharmacokinetic trial of six doses of artemether-lumefantrine for multidrug-resistant Plasmodium falciparum malaria in ThailandG Lefevre
Novartis Pharma, International Clinical Development, Basel, Switzerland
Am J Trop Med Hyg 64:247-56. 2001..These results confirm the excellent safety and efficacy of the six-dose regimen of artemether-lumefantrine in the treatment of multidrug-resistant P. falciparum malaria...
Efficacy of artesunate plus amodiaquine versus that of artemether-lumefantrine for the treatment of uncomplicated childhood Plasmodium falciparum malaria in Zanzibar, TanzaniaAndreas Martensson
Infectious Diseases Unit, Department of Medicine, Karolinska University Hospital, Karolinska Institute, Stockholm, Sweden
Clin Infect Dis 41:1079-86. 2005..Children who were 9-59 months of age and who weighted > or =9 kg were randomly assigned to receive either ASAQ or AL for 3 days in standard doses. Intention-to-treat analyses were performed...
Artemisinin-based combinationsElizabeth A Ashley
Shoklo Malaria Research Unit, Mae Sot, Tak, Thailand
Curr Opin Infect Dis 18:531-6. 2005..Artemisinin-based combination treatments have consistently been shown to be highly effective and safe. The challenge is to make them accessible in tropical countries...
Effect of artemether-lumefantrine policy and improved vector control on malaria burden in KwaZulu-Natal, South AfricaKaren I Barnes
Division of Clinical Pharmacology, University of Cape Town, Cape Town, South Africa
PLoS Med 2:e330. 2005..Malaria is diagnosed definitively and treatment is provided free of charge in reasonably accessible public-sector health-care facilities...
Research Grants
- Training in Endocrinology, Diabetes, Clinical NutritionRobert Klein; Fiscal Year: 2007..This program seeks to train independent academic endocrinologists who will function as independent laboratory scientists capable of developing research programs that address endocrine disorders in the future. ..
- Carcinogenicity of EstrogensDAVID SPINK; Fiscal Year: 2007..These studies may elucidate roles of estrogen in the regulation of Ah responsiveness, CYP1 expression, and carcinogen bioactivation that may lead to novel breast cancer chemoprevention strategies. ..
- Carcinogen Exposure and Adult Cancer RiskCHARLENE MCQUEEN; Fiscal Year: 2007..Since tumors are characterized by an accumulation of genetic changes, increasing the mutational burden with exposures early in life has the potential to increase adult cancer risk. ..
- THE ROLE OF SULFATIDES IN ALZHEIMER'S DISEASEXianlin Han; Fiscal Year: 2007..abstract_text> ..
- SYNTHESIS OF ANTIBIOTICSK Nicolaou; Fiscal Year: 2007....
- Study of a New Class of Chiral Nucleophilic CatalystsVLADIMIR BIRMAN; Fiscal Year: 2007....
- TOTAL SYNTHESIS OF AZADIRACHTINK Nicolaou; Fiscal Year: 2007..The proposed work is expected to impact the general areas of pharmaceutical and agricultural research, and infectious diseases in particular, through discoveries in synthetic organic chemistry and chemical biology. ..
- Small molecule inhibitors of bacterial secretion systemVincent Lee; Fiscal Year: 2007..Furthermore, the small molecule inhibitors identified in this proposal may be used as a starting point for the development of therapeutics to inhibit bacterial infection caused by Gram-negative pathogens that utilize type III secretion. ..
- The Cytoskeletal System in Preservation InjuryMartin J Mangino; Fiscal Year: 2010..This will reveal novel therapeutic targets to focus treatments and help alleviate the donor shortage. ..
- Roles of CYP1 & 19 in Fundulus Steroids & PAH MetabolismKristine Willett; Fiscal Year: 2009..This research will further define the utility of Fundulus as a model organism for studying PAH-associated toxicities and in the development of human CYP19 or CYP1 B-related therapeutics. ..
- Investigating the Molecular Mechanism of Hexose-induced Stress in Lens and RetinaPeter F Kador; Fiscal Year: 2010..Moreover, these studies should help identify new drug targets for the treatment of these diabetic complications. ..
- Sequence Effects of Arylamine-DNA Adducts: Repair and ReplicationBongsup P Cho; Fiscal Year: 2010..The key molecular players (adduct structures, polymerases, repair proteins) producing adverse outcomes must be identified, characterized, and understood in order to devise appropriate prevention and risk assessment strategies. ..
- Effective Countermeasures to Anthrax and Botulinum ToxinYuan Ping Pang; Fiscal Year: 2003..It complements the efforts of other workers in developing methods for rapidly identifying anthrax and botulinum toxin. ..
- PHYSIOLOGICALLY ACTIVE NATURAL PRODUCTSDouglass Taber; Fiscal Year: 2003..Specific targets include the cognition-enhancing alkaloid huperzine A, morphine, the parent compound of the morphine alkaloids, and N-deacetyllappaconitine, representative of the Delphinium diterpenoid alkaloids. ..
- Prevention of Breast Cancer-Targeting COX-2 & PPARgammaALAA BADAWI; Fiscal Year: 2003..abstract_text> ..
- TOTAL SYNTHESIS OF THIOSTREPTONK Nicolaou; Fiscal Year: 2005..The disease areas likely to benefit most from the proposed investigations are bacterial-caused diseases and malaria. ..
- Enabling Technologies for Combinatorial ChemistryK Nicolaou; Fiscal Year: 2005..abstract_text> ..
- REACTIVE INTERMEDIATES OF CARCINOGENESIS OF PAHSKENNETH LAALI; Fiscal Year: 2004..DNA binding and mammalian cell mutagenicity studies on the substituted and derivatized-PAHs proposed for stable ion work will enhance the available literature data on structure/reactivity relationships. ..
- IMMUNE RESPONSES TO P FALCIPARUM IN HIGHLAND KENYAChandy John; Fiscal Year: 2002..falciparum antigens to susceptibility to infection and disease is important in the evaluation of these antigens as malaria vaccine candidates. ..
- Pathogenesis of cognitive/neurologic deficits in central nervous system malariaChandy C John; Fiscal Year: 2010..The study therefore has the potential to lead to the prevention of brain injury in hundreds of thousands of children in sub-Saharan Africa. ..
- Carcinogenicity of EstrogensDAVID SPINK; Fiscal Year: 2009..These studies may elucidate roles of estrogen in the regulation of Ah responsiveness, CYP1 expression, and carcinogen bioactivation that may lead to novel breast cancer chemoprevention strategies. ..
- Pathogenesis of cognitive/neurologic deficits in central nervous system malariaChandy C John; Fiscal Year: 2010..The study therefore has the potential to lead to the prevention of brain injury in hundreds of thousands of children in sub-Saharan Africa. ..
- Pathogenesis of cognitive/neurologic deficits in central nervous system malariaChandy John; Fiscal Year: 2009..The study therefore has the potential to lead to the prevention of brain injury in hundreds of thousands of children in sub-Saharan Africa. ..
- Investigating the Molecular Mechanism of Hexose-induced Stress in Lens and RetinaPeter Kador; Fiscal Year: 2007..Moreover, these studies should help identify new drug targets for the treatment of these diabetic complications. ..
- Congenital and neonatal malaria in MaliAbdoulaye Djimde; Fiscal Year: 2006..research grant ..
- Malaria transmission and immunity in highland KenyaChandy John; Fiscal Year: 2007..We anticipate that our findings will generate strategies for vaccine induction of robust immune responses against multiple antigenic variants in vulnerable populations experiencing malaria epidemics. ..
- The effects of A2A adenosine receptor agonists in sepsisChristopher Moore; Fiscal Year: 2007..e., endotoxemia. These aims are proposed to identify crucial components in sepsis pathophysiology and characterize what is potentially a useful tool in the therapeutic arsenal used to combat sepsis. ..
- Multifunctional Antioxidants as Anti-Cataract AgentsPeter Kador; Fiscal Year: 2007....
- CARCINOGENICITY OF B RING UNSATURATED ESTROGENSDAVID SPINK; Fiscal Year: 2003..abstract_text> ..
- Adipocyte-specific glucocorticoid metabolism: 11betaHSDsERIN KERSHAW; Fiscal Year: 2007..The ultimate goal is for the applicant to become an independent investigator. ..
- Host Polymorphisms and Uncomplicated MalariaSunil Parikh; Fiscal Year: 2007..Parikh will be able to utilize modern molecular epidemiology techniques to investigate human genetic factors underlying susceptibility to malaria and he will be well equipped for a career in academic research. ..
- Contribution of ATGL in skeletal muscle to lipid metabolism and insulin actionERIN KERSHAW; Fiscal Year: 2007..Evaluating the role of ATGL-mediated fat breakdown in skeletal muscle will provide important insights into the pathophysiology and treatment of obesity, insulin resistance, and related metabolic disorders. ..
- Burden of Malaria in Pregnancy in IndiaDavidson Hamer; Fiscal Year: 2007..The information generated by the study will also be instrumental in the development of new programs for preventing and mitigating the impact of MIP in India. ..
